| DB ID | MyCo_5715 |
| Title | Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis |
| Year | 2022 |
| PMID | 35843498 |
| Fungal Diseases involved | Cryptococcal meningitis |
| Associated Medical Condition | HIV-AIDS |
| Genus | Cryptococcus |
| Species | neoformans |
| Organism | Cryptococcus neoformans |
| Ethical Statement | The parent trials received institutional review board approval from the appropriate US, UK, and Ugandan institutions, including the Uganda National Drug Authority and Uganda National Council of Science and Technology. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Plasma |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Cytomegalovirus viremia |
| Biomarker Full Name | Cytomegalovirus viremia |
| Biomarker Type | Diagnostic |
| Biomolecule | None |
| Geographical Location | USA |
| Cohort | Here included 308 persons with cryptococcal meningitis and 32 with TB meningitis. |
| Cohort No. | 340 |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | PCR |
| Analysis Method | qRT-PCR |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | qRT-PCR |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
